Ambrx Company
Ambrx develops protein therapeutics that preserve potency, reduce dosing frequency, and improve homogeneity of the drug substance.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
La Jolla, California, United States
Founded Date:
2003
Estimated Revenue:
$10M to $50M
Register and Claim Ownership